Search Results

Innovative Medicine

September 27, 2013

Japanese Health Authority Approves SOVRIAD™ For The Treatment Of Genotype-1 Chronic HCV Infection

Japan is the first country in the world where SOVRIAD™ is approved

Research

September 25, 2013

Janssen R&D Ireland Announces Agreement with PATH for Early Development of Rilpivirine in Long-Acting Formulation for Potential Prophylactic Intervention

Innovative Medicine

September 24, 2013

Janssen Healthcare Innovation Launches Care4Today™ Mobile Health Manager 2.0

Free two-way secure messaging platform, mobile app and website introduces new Care4Charity™ and Care4Family™ features to motivate users to take medications on schedule and support caregivers

Innovative Medicine

September 23, 2013

STELARA® (Ustekinumab) Receives FDA Approval To Treat Active Psoriatic Arthritis

First and Only Anti-IL-12/23 Treatment Approved for Adult Patients Living with Psoriatic Arthritis

Innovative Medicine

September 23, 2013

SIMPONI® Receives European Commission Approval For Treatment Of Moderately To Severely Active Ulcerative Colitis

First and Only Subcutaneous Biologic Treatment Administered Every Four Weeks Approved for Ulcerative Colitis

Innovative Medicine

September 23, 2013

STELARA® Receives European Commission Approval For Treatment Of Active Psoriatic Arthritis

Approval marks a new biologic treatment with alternative mechanism for complex inflammatory disease

Innovative Medicine

September 20, 2013

INVOKANA® (canagliflozin) Receives Positive Opinion Recommending Approval In The European Union For The Treatment Of Adults With Type 2 Diabetes Mellitus[1]

Innovative Medicine

September 20, 2013

Pooled Analysis Confirms XARELTO® has Similar Efficacy and Reduces the Incidence of Major Bleeding by Nearly Half Compared to Standard of Care in Treatment of DVT and PE

Analysis Published in the Thrombosis Journal

Innovative Medicine

September 3, 2013

Simultaneous Applications Submitted to FDA and EMA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder

Innovative Medicine

August 19, 2013

Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.

Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline

Search Results

No Results

Search Results

You are now leaving jnj.com/innovativemedicine